000			02124 a2200553 4500
005			20250515020300.0
264		0	_c20060606
008			200606s 0 0 eng d
022			_a0305-7372
024	7		_a10.1016/j.ctrv.2006.01.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aBergstralh, Daniel T
245	0	0	_aMicrotubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. _h[electronic resource]
260			_bCancer treatment reviews _cMay 2006
300			_a166-79 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAlkanes _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aCarbamates _xpharmacology
650	0	4	_aCyclooxygenase 2 _xmetabolism
650	0	4	_aDiterpenes _xpharmacology
650	0	4	_aEpothilones _xpharmacology
650	0	4	_aHumans
650	0	4	_aInhibitor of Apoptosis Proteins _xmetabolism
650	0	4	_aInterleukin-1 _xmetabolism
650	0	4	_aInterleukin-8 _xmetabolism
650	0	4	_aLactones _xpharmacology
650	0	4	_aMAP Kinase Kinase 1 _xmetabolism
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aMacrolides
650	0	4	_aMaturation-Promoting Factor _xmetabolism
650	0	4	_aMicrotubule-Associated Proteins _xmetabolism
650	0	4	_aMicrotubules _xdrug effects
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aNeoplasm Proteins _xmetabolism
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aPyrones _xpharmacology
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSurvivin
650	0	4	_aTaxoids _xpharmacology
650	0	4	_aTumor Suppressor Protein p53 _xmetabolism
700	1		_aTing, Jenny P-Y
773	0		_tCancer treatment reviews _gvol. 32 _gno. 3 _gp. 166-79
856	4	0	_uhttps://doi.org/10.1016/j.ctrv.2006.01.004 _zAvailable from publisher's website
999			_c16136776 _d16136776